Roche invites innovative partnership proposals for novel therapies, technologies, and digital health solutions addressing unmet medical needs in key therapeutic areas.
Funder: Roche
Due Dates: Rolling
Funding Amounts: Partnership terms, funding, and structures are flexible and negotiated case-by-case; no fixed award size or duration.
Summary: Roche seeks innovative partnership proposals for assets, technologies, or collaborations addressing unmet needs in key therapeutic and digital health areas.
Key Information: Proposals are not accepted for generics, biosimilars, OTCs, or animal health.
Roche is actively seeking partnership opportunities with organizations, academic institutions, and companies developing innovative solutions in healthcare. Their focus is on first-in-class or best-in-disease molecules, novel targets, enabling modalities, digital technologies, data sets, and advanced analytics. Proposals should address significant unmet medical needs, demonstrate strong scientific rationale, and offer clear therapeutic or technological differentiation. Roche is open to a range of partnership models, including collaborations, licensing, and acquisitions, across their core areas of interest.
Roche does not consider proposals related to generics, biosimilars, over-the-counter (OTC) products, or animal health.